Loading clinical trials...
Loading clinical trials...
A Phase 2b, Dose-ranging, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study in Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy
Conditions
Interventions
Placebo
Sotagliflozin
Locations
17
United States
Lexicon Investigational Site
Concord, California, United States
Lexicon Investigational Site
Ventura, California, United States
Lexicon Investigational Site
Denver, Colorado, United States
Lexicon Investigational Site
Jacksonville, Florida, United States
Lexicon Investigational Site
Miami, Florida, United States
Lexicon Investigational Site
Springfield, Illinois, United States
Start Date
July 1, 2015
Primary Completion Date
August 1, 2016
Completion Date
August 1, 2016
Last Updated
February 12, 2020
NCT07224321
NCT06474598
NCT07051005
NCT02734277
NCT06575426
NCT07356089
Lead Sponsor
Lexicon Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions